Clinical Trials Directory

Trials / Completed

CompletedNCT00309751

Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

Study of Pitavastatin Vs. Atorvastatin (Following Up-Titration) in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
418 (actual)
Sponsor
Kowa Research Europe · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the efficacy and safety of pitavastatin with that of atorvastatin in patients with type II diabetes mellitus (type II DM) and combined dyslipidemia.

Conditions

Interventions

TypeNameDescription
DRUGPitavastatinPitavastatin 4 mg QD
DRUGAtorvastatinAtorvastatin 20 mg

Timeline

Start date
2005-12-01
Primary completion
2007-06-01
Completion
2007-06-01
First posted
2006-04-03
Last updated
2010-02-23
Results posted
2010-01-18

Locations

35 sites across 6 countries: Denmark, Germany, India, Netherlands, Poland, United Kingdom

Source: ClinicalTrials.gov record NCT00309751. Inclusion in this directory is not an endorsement.

Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia (NCT00309751) · Clinical Trials Directory